Shares of Moderna Inc. mRNA,
rose 6.48% on Wednesday to $ 116.26 in what turned out to be a general mixed trading session for the stock market with Dow Jones Industrial Average DJIA,
up 1.44% to 30,829.40 and the NASDAQ COMP Composite Index,
decreasing by 0.61% to 12,740.79. Moderna Inc. closed at $ 62.24 below the 52-week high ($ 178.50), which the company hit on Dec. 1.
The stock market surpassed some of its competitors on Wednesday as AbbVie Inc. Abbvie,
fell 0.86% to $ 105.58, Amgen Inc. AMGN,
increased by 2.41% to USD 233.25, and AstraZeneca PLC ADR AZN,
increased 0.41% to $ 50.91. Trading volume (21.4 million) remained at 3.9 million below its 50.2-day average volume of 25.2 million.